- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
OIF Antibody recognizes osteoglycin (OGN), an extracellular matrix protein also known as osteoinductive factor, mimecan and SLRR3A. Osteoglycin belongs to the small leucine-rich proteoglycan family, a group of extracellular proteins characterized by tandem leucine-rich repeat motifs. Members of this family interact with structural and signaling components of the extracellular matrix and contribute to the organization, assembly and remodeling of connective tissues. OGN was initially identified through studies of bone-associated proteins and subsequently characterized in a variety of tissues.
Osteoglycin is synthesized as a secreted precursor that undergoes post-translational processing and glycosylation. The mature protein contains leucine-rich repeats that contribute to protein-protein interactions within the extracellular environment. OGN can associate with collagen-containing matrices and has been implicated in the regulation of collagen fibrillogenesis and extracellular matrix architecture. An Osteoinductive Factor Polyclonal Antibody can therefore support studies examining OGN expression in connective tissue organization, matrix remodeling and tissue homeostasis.
Despite its historical designation as osteoinductive factor, OGN is not restricted to bone biology. Its expression has been investigated in cardiovascular, pulmonary, skeletal and other connective tissues, where it may influence structural organization and responses to tissue injury. Osteoglycin has also been linked to regulation of cell growth, differentiation and signaling pathways that operate within the extracellular matrix microenvironment. Changes in OGN expression have consequently been studied in fibrosis, cardiovascular remodeling, musculoskeletal biology and cancer.
Osteoglycin is particularly interesting because its apparent molecular weight can vary substantially depending on processing and glycosylation. The predicted polypeptide is approximately 34 kDa, while experimentally detected forms can migrate at higher molecular weights. This biochemical heterogeneity reflects the extracellular and post-translationally modified nature of OGN and should be considered when evaluating protein expression. NSJ Bioreagents provides this Osteoinductive Factor Polyclonal Antibody for research into OGN biology and extracellular matrix regulation.
An OIF Antibody can be used to investigate osteoglycin expression, extracellular matrix organization, collagen-associated biology, connective tissue remodeling and signaling processes involving this small leucine-rich proteoglycan.
Explore additional reagents for extracellular matrix and cellular signaling research in our Signal Transduction Antibodies collection.
Optimal dilution of the OIF Antibody / Osteoinductive Factor Polyclonal Antibody should be determined by the researcher.
A mouse partial recombinant protein corresponding to amino acids A20-F298 was used as the immunogen for the Oif antibody.
After reconstitution, the Oif antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Osteoinductive Factor antibody, Osteoglycin antibody, OGN antibody, Mimecan antibody, Osteoglycin Precursor antibody, SLRR3A antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.